CBDY - Target Group Inc.
0.0018
0.000 22.222%
Share volume: 200
Last Updated: 03-27-2026
Pharmaceutical Products/Medicinal Chemicals:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.29%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 08-08-2024 | 11-07-2024 | 03-27-2025 | 05-09-2025 | 08-12-2025 | 11-07-2025 | |
| Total revenue | 2.275 M | 541.113 K | 0.000 | 1.400 M | 1.246 M | 499.650 K | |
| Cost of revenue | 806.184 K | 173.006 K | 0.000 | 629.612 K | 500.303 K | 235.291 K | |
| Gross profit | 1.469 M | 368.107 K | 0.000 | 770.827 K | 745.421 K | 264.359 K | |
| -74.94% | -100.00% | -3.30% | -64.54% | ||||
| Operating expenses | 178.296 K | 235.086 K | 0.000 | 53.842 K | 197.697 K | 111.086 K | |
| Selling general and admin | 178.296 K | 235.086 K | 0.000 | 53.842 K | 197.697 K | 111.086 K | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 567.671 K | 605.888 K | 0.000 | 617.253 K | 608.294 K | 520.011 K | |
| 6.73% | -100.00% | -1.45% | -14.51% | ||||
| Operating income | 901.156 K | -237.781 K | 0.000 | 153.574 K | 137.127 K | -255.652 K | |
| Ebit | 939.724 K | -269.560 K | 0.000 | 126.062 K | 26.911 K | -212.936 K | |
| Pretax income | 666.664 K | -528.950 K | 0.000 | -108.213 K | -219.770 K | -479.392 K | |
| -179.34% | -100.00% | 103.09% | 118.13% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 666.664 K | -528.950 K | 0.000 | -108.213 K | -219.770 K | -479.392 K | |
| -179.34% | 100.00% | -103.09% | -118.13% |